Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Composition of French National Commission for the Evaluation of Medical Devices and Health Technologies renewed

The National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) is responsible for evaluating medical devices, procedures and health technologies within HAS. Their evaluations are the basis for reimbursement decisions. In 2017, 215 medical devices were assessed, and 89% of the evaluated devices were required to be reimbursed.

The commission is composed of experts chosen for their scientific expertise and members of patient associations. One-third of the appointed members are new to the Commission. In order to adapt to the new challenges of the sector, the commission included an oncologist, an expert in e-health, and a methodologist specialized in small studies. Lastly, a general practitioner is again a member of the specialized commission. The HAS college renewed the composition of the CNEDiMTS for a period of three years. 

In total, it has 29 members, of which 22 are holders of voting rights and 7 are alternates with advisory votes. It also hosts 7 members with consultative votes representing the central directorates of the Ministry of Health and the various health insurance funds. Isabelle Adenot, the member of the college of HAS, is the head of the commission. 

The new commission will meet for the first time on November 6, 2018.

See the full report and the entire composition of the Commission here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.